. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology. 1999 May 12;52(8):1555-62. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(150)
521.7 ± 197.4
pg/mL §
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
Aβ42
(CSF)
CTRL-
Other controls
(100)
873.6 ± 292.5
pg/mL §
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
AD
(150)
520.1 ± 321.5
pg/mL §
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
CTRL-
Other controls
(100)
228.5 ± 149.1
pg/mL §
ELISA;
Innotest;
Innogenetics

§ Data supplied to Alzforum by author

Recommends

Please login to recommend the paper.

Comments

Comments on this Paper

No Available Comments

Make a Comment

To make a comment you must login or register.